Plasma Proteomics To Identify the Biomarkers and Pathogenesis of Mild Cognitive Impairment-Reference-Cited by-同舟云学术

Plasma Proteomics To Identify the Biomarkers and Pathogenesis of Mild Cognitive Impairment

Published:2022 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Hou Zhitao,Sun Ailin,Song Xiaochen,Liu Shu,Hu Xinying,Luan Yihan,Guan Huibo,He Changyuan,Sun Yuefeng,Chen Jing

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference44 articles.

1. Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment;J T S Z Anderson;JAMA

2. Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia;D M M E Gunak;JAMA Psychiatry

3. Brief Cognitive Tests for Distinguishing Clinical Alzheimer-Type Dementia From Mild Cognitive Impairment or Normal Cognition in Older Adults With Suspected Cognitive Impairment;E L S J Hemmy;Ann Intern Med

4. Effect of transcranial magnetic stimulation as an enhancer of cognitive stimulation sessions on mild cognitive impairment: Preliminary results;R R Gy;Psychiatry Res

5. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study;D L Y Jia;Lancet Public Health

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Are the Reliable Plasma Biomarkers for Mild Cognitive Impairment? A Clinical 4D Proteomics Study and Validation;Mediators of Inflammation;2024-05-27